Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Preparation of brain-targeted bionic nano-drug delivery system and application thereof to brain glioma treatment

A nano-drug and nano-particle technology, applied in the field of medicine, achieves the effects of low cytotoxicity, reduced toxicity and strong destructive effect

Inactive Publication Date: 2015-11-25
SECOND MILITARY MEDICAL UNIV OF THE PEOPLES LIBERATION ARMY
View PDF4 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0010] At present, there is no relevant report on the construction of a multi-target nano-drug delivery system that crosses the blood-brain barrier and targets new blood vessels derived from glioma cells and glioma stem cells; Modified Angiopep-2 on the surface apolipoprotein to obtain a new type of nano drug delivery system with good biocompatibility and salinomycin

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation of brain-targeted bionic nano-drug delivery system and application thereof to brain glioma treatment
  • Preparation of brain-targeted bionic nano-drug delivery system and application thereof to brain glioma treatment
  • Preparation of brain-targeted bionic nano-drug delivery system and application thereof to brain glioma treatment

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0064] Example 1: Linkage of LDL-linked small peptides

[0065] Take 10 mg low-density lipoprotein (Prospec Company, purity 98%), add 10 μg Angiopep-2 (Qiangyao Biotechnology Co., Ltd.), and stir in PBS with pH 8 in the dark for 10 hours.

[0066] After 10 hours, it was placed in deionized water and dialyzed at 4° for 24 hours to remove unbound small peptides.

Embodiment 2

[0067] Embodiment 2: Preparation of low-density lipoprotein nanoparticles loaded with salinomycin sodium

[0068] 10 mg of low-density lipoprotein linked to small peptides prepared in Example 1 was added with 5 mg of starch as a lyoprotectant, and then freeze-dried. Add an appropriate amount of 4 ° pre-cooled heptane, shake vigorously for about 60 seconds, so that the freeze-dried powder and heptane are fully mixed. Centrifuge at 2000rpm for 10min, discard the light yellow supernatant, repeat extraction several times until the supernatant is colorless and discard.

[0069] 2mg salinomycin (TEKU-E company, purity more than 99%) mixed with 0.5mgDHA (Nu-chek company, purity 99%, CAS#6217-54-5) was dissolved in heptane, mixed with 15mg protein starch mixture at 4 °Incubate for 2 hours. The heptane was slowly evaporated in a nitrogen stream on ice until the sample was completely dry. Add an appropriate amount of saline to the dry sample, stir gently to resuspend, and incubate at...

Embodiment 3

[0070] Embodiment 3: the particle diameter of nanoparticle and potential measurement

[0071] The micro-nanoparticles prepared in Example 2 were taken and diluted to 1 mL, and the particle size and zeta potential were measured by dynamic light scattering. The results show that the nanoparticle size is uniform, about 20nm, and the zeta potential is about -5mV, such as figure 1 shown.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
particle diameteraaaaaaaaaa
particle diameteraaaaaaaaaa
Login to View More

Abstract

The invention relates to the technical field of medicine, in particular to preparation of a brain-targeted bionic nano-drug delivery system and application thereof to brain glioma treatment. The brain-targeted bionic nano-drug delivery system adopts an LDL (low-density lipoprotein) and DHA (docosahexaenoic acid) compound as a vector to modify Angiopep-2 on surface apolipoprotein and encapsulate salinomycin. The brain-targeted bionic nano-drug delivery system has the advantages of good biocompatibility and no immunogenicity; under the action of transcytosis mediated by LRP-1 (low-density lipoprotein receptor-related protein 1) expressed in blood brain barrier, the brain-targeted bionic nano-drug delivery system targets to penetrate the blood brain barrier actively; after entering the brain, the brain-targeted bionic nano-drug delivery system targets spongioblastoma by means of common mediation of an LDLR (low-density lipoprotein receptor) and an LRP-1 receptor, and kills tumor cells, tumor stem cells and multiple target points of tumor angiogenic blood vessels. The preparation of the brain-targeted bionic nano-drug delivery system and application thereof to brain glioma treatment provide a safer, more efficient and atraumatic drug-delivery way for treatment of tumors of the central nervous system.

Description

Technical field: [0001] The invention relates to the technical field of medicine, in particular to a bionic nano drug delivery system for actively targeting brain glioma to deliver drugs and a preparation method thereof. The drug delivery system carrier of the present invention is a natural small particle size lipoprotein, which is modified by a functional peptide with active targeting, through the low-density lipoprotein receptor-related transmembrane receptor protein LRP expressed on the blood-brain barrier -1 mediated through the blood-brain barrier, while targeting glioma mediated by low-density lipoprotein receptor and LRP-1, targeting glioma cells, glioma stem cells and glioma neovascularization Point killing, to achieve therapeutic effect. Background technique: [0002] Glioma is the most common malignant tumor of the central nervous system, occurring in the neuroectoderm, derived from astrocytes or oligodendrocytes, accounting for 35-60% of intracranial tumors. Acc...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/14A61K47/48A61K48/00A61K31/7048A61P35/00
Inventor 俞媛钟延强耿雯倩鲁莹邹豪高洁陈琰张翮孙治国解方园
Owner SECOND MILITARY MEDICAL UNIV OF THE PEOPLES LIBERATION ARMY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com